{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:06:47Z","timestamp":1770977207406,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Mundipharma Pte Ltd, Singapore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12891-017-1664-4","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T12:45:20Z","timestamp":1501850720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain"],"prefix":"10.1186","volume":"18","author":[{"given":"Do Heum","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Il","family":"Bin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Kin-Cheong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun Kee","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"In","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyoungmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Javier","family":"Lichauco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Chiu","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Wan","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony Kwun-Tung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester Gonzales","family":"Penserga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Ah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlim","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"1664_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/acprof:oso\/9780199235766.003.0001","volume-title":"Chronic pain epidemiology","author":"P Croft","year":"2010","unstructured":"Croft P, Blyth FM, van der Windt D. Chronic pain as a topic for epidemiology and public health. In: Croft P, Blyth FM, van der Windt D, editors. Chronic pain epidemiology. Oxford University Press: Academic; 2010. p. 3\u20138."},{"key":"1664_CR2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","volume":"16","author":"W Zhang","year":"2008","unstructured":"Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil. 2008;16:137\u201362.","journal-title":"Osteoarthr Cartil"},{"key":"1664_CR3","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1503\/cmaj.051528","volume":"174","author":"AD Furlan","year":"2006","unstructured":"Furlan AD. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Can Med Assoc J. 2006;174:1589\u201394.","journal-title":"Can Med Assoc J"},{"key":"1664_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","volume":"112","author":"E Kalso","year":"2004","unstructured":"Kalso E, Edwards JE, Moore AR, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain. 2004;112:372\u201380.","journal-title":"Pain"},{"key":"1664_CR5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1465-3362.2010.00271.x","volume":"30","author":"W Ling","year":"2011","unstructured":"Ling W, Mooney L, Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug and alcohol review. 2011;30:300\u20135.","journal-title":"Drug and alcohol review"},{"key":"1664_CR6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315:1624\u201345.","journal-title":"JAMA"},{"key":"1664_CR7","doi-asserted-by":"crossref","first-page":"E659","DOI":"10.1503\/cmaj.170363","volume":"189","author":"JW Busse","year":"2017","unstructured":"Busse JW, Craigie S, Juurlink DN, Buckley DN, Wang L, Couban RJ, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189:E659\u201366.","journal-title":"CMAJ"},{"key":"1664_CR8","doi-asserted-by":"crossref","unstructured":"O'Brien T, Christrup LL, Drewes AM, Fallon MT, Kress HG, McQuay HJ, et. al. European pain federation position paper on appropriate opioid use in chronic pain management. Eur J Pain 2017;21:3\u201319.","DOI":"10.1002\/ejp.970"},{"key":"1664_CR9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/JMDH.S38562","volume":"6","author":"MJ Brennan","year":"2013","unstructured":"Brennan MJ. Update on prescription extended-release opioids and appropriate patient selection. J Multidiscip Healthc. 2013;6:265\u201380.","journal-title":"J Multidiscip Healthc"},{"key":"1664_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.aat.2015.06.001","volume":"53","author":"JV Pergolizzi Jr","year":"2015","unstructured":"Pergolizzi JV Jr, Scholten W, Smith KJ, Leighton-Scott J, Willis JC, Henningfield JE. The unique role of transdermal buprenorphine in the global chronic pain epidemic. Acta Anaesthesiol Taiwanica. 2015;53:71\u20136.","journal-title":"Acta Anaesthesiol Taiwanica"},{"key":"1664_CR11","first-page":"115","volume":"2","author":"R Likar","year":"2006","unstructured":"Likar R. Transdermal buprenorphine in the management of persistent pain \u2013 safety aspects. Ther Clin Risk Manag. 2006;2:115\u201325.","journal-title":"Ther Clin Risk Manag"},{"key":"1664_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","volume":"13","author":"HG Kress","year":"2009","unstructured":"Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J of Pain. 2009;13:219\u201330.","journal-title":"Eur J of Pain"},{"key":"1664_CR13","unstructured":"Norspan\u00ae Package insert. Mundipharma (Hong Kong) Limited, Hong Kong, 2011."},{"key":"1664_CR14","unstructured":"Norspan\u00ae Summary of product characteristics. Mundipharma Korea Ltd., Korea 2013."},{"key":"1664_CR15","unstructured":"Norspan\u00ae Patient information leaflet. Mundipharma Distribution GmbH (Philippine Branch), Philippines, 2010."},{"key":"1664_CR16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","volume":"41","author":"PJ Hoskin","year":"1991","unstructured":"Hoskin PJ, Hanks GW. Opioid agonist-antagonist drugs in acute and chronic pain states. Drugs. 1991;41:326\u201344.","journal-title":"Drugs"},{"key":"1664_CR17","doi-asserted-by":"crossref","unstructured":"Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E, et. al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth 2006;96:627\u2013632.","DOI":"10.1093\/bja\/ael051"},{"key":"1664_CR18","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1533-2500.2010.00378.x","volume":"10","author":"J Pergolizzi","year":"2010","unstructured":"Pergolizzi J, Aloisi AM, Dahan A, Filitz J, Langford R, Likar R, et al. Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract. 2010;10:428\u201350.","journal-title":"Pain Pract"},{"key":"1664_CR19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00228-012-1320-8","volume":"69","author":"N Al-Tawil","year":"2013","unstructured":"Al-Tawil N, Odar-Cederlof I, Berggren AC, Johnson HE, Persson J. Pharmacokinetics of transdermal buprenorphine patch in the elderly. Eur J Clin Pharmacol. 2013;69:143\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"1664_CR20","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","volume":"10","author":"J Filitz","year":"2006","unstructured":"Filitz J, Griessinger N, Sittl R, Likar R, Sch\u00fcttler J, Koppert W. Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J of Pain. 2006;10:743\u20138.","journal-title":"Eur J of Pain."},{"key":"1664_CR21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8:287\u2013313.","journal-title":"Pain Pract."},{"key":"1664_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/JPR.S6503","volume":"2","author":"G Hans","year":"2009","unstructured":"Hans G, Robert D. Transdermal buprenorphine - a critical appraisal of its role in pain management. J Pain Res. 2009;2:117\u201334.","journal-title":"J Pain Res"},{"key":"1664_CR23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.joca.2011.03.011","volume":"19","author":"PG Conaghan","year":"2011","unstructured":"Conaghan PG, O\u2019Brien CM, Wilson M, Schofield JP. Transdermal buprenorphine plus oral paracetamol vs an oral codeine-paracetamol combination for osteoarthritis of hip and\/or knee: a randomised trial. Osteoarthr Cartil. 2011;19:930\u20138.","journal-title":"Osteoarthr Cartil"},{"key":"1664_CR24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1155\/2010\/216725","volume":"15","author":"A Gordon","year":"2010","unstructured":"Gordon A, Rashiq S, Moulin DE, Clark AJ, Beaulieu AD, Eisenhoffer J, et al. Buprenorphine transdermal system for opioid therapy in patients with chronic low back pain. Pain Res Manag. 2010;15:169\u201378.","journal-title":"Pain Res Manag"},{"key":"1664_CR25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.clinthera.2009.03.001","volume":"31","author":"M Karlsson","year":"2009","unstructured":"Karlsson M, Berggren A-C. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 \u03bcg\/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study. Clinl Ther. 2009;31:503\u201313.","journal-title":"Clinl Ther"},{"key":"1664_CR26","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1185\/03007995.2013.873714","volume":"30","author":"J Karlsson","year":"2014","unstructured":"Karlsson J, Soderstrom A, Augustini BG, Berggren AC. Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study. Curr Med Res Opin. 2014;30:575\u201387.","journal-title":"Curr Med Res Opin"},{"key":"1664_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002508-198906000-00005","volume":"5","author":"MP Jensen","year":"1989","unstructured":"Jensen MP, Karoly P, O'Riordan EF, Bland F Jr, Burns RS. The subjective experience of acute pain. An assessment of the utility of 10 indices. Clin J Pain. 1989;5:153\u20139.","journal-title":"Clin J Pain"},{"key":"1664_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"1664_CR29","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpain.2009.01.258","volume":"10","author":"L Ferguson","year":"2009","unstructured":"Ferguson L, Scheman J. Patient global impression of change scores within the context of a chronic pain rehabilitation program. J Pain. 2009;10:S73.","journal-title":"J Pain"},{"key":"1664_CR30","first-page":"28","volume":"4","author":"J Busner","year":"2007","unstructured":"Busner J, Targum SD. The clinical global impressions scale: applying a research tool in clinical practice. Psychiatry (Edgmont). 2007;4:28\u201337.","journal-title":"Psychiatry (Edgmont)"},{"key":"1664_CR31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149\u201358.","journal-title":"Pain"},{"key":"1664_CR32","first-page":"1","volume":"94","author":"VJ Burroughs","year":"2002","unstructured":"Burroughs VJ, Maxey RW, Levy RA. Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Medl Assoc. 2002;94:1\u201326.","journal-title":"J Natl Medl Assoc"},{"key":"1664_CR33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.clinthera.2010.04.018","volume":"32","author":"A Gordon","year":"2010","unstructured":"Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O'Mahony W, et al. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther. 2010;32:844\u201360.","journal-title":"Clin Ther"},{"key":"1664_CR34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","volume":"10","author":"R Chou","year":"2009","unstructured":"Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, et al. American pain society-American Academy of pain medicine opioids guidelines panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113\u201330.","journal-title":"J Pain"},{"key":"1664_CR35","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. The Lancet Oncology. 2012;13:e58\u201368.","journal-title":"The Lancet Oncology"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-017-1664-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T01:24:53Z","timestamp":1569979493000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-017-1664-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1664"],"URL":"https:\/\/doi.org\/10.1186\/s12891-017-1664-4","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]},"article-number":"337"}}